The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Parenteral Dosage Form Market Research Report 2025

Global Parenteral Dosage Form Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1677755

No of Pages : 87

Synopsis
Global Parenteral Dosage Form market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Parenteral Dosage Form market research.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Parenteral Dosage Form market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Ashland
Tepnel Pharma Services
Ascendia Pharmaceuticals
Thermo Fisher Scientific
ProJect Pharmaceutics
Lonza
BOC Sciences
Segment by Type
Emulsions for Injection
Powders for Injection
Gels for Injection
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Parenteral Dosage Form report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Parenteral Dosage Form Market Overview
1.1 Product Overview and Scope of Parenteral Dosage Form
1.2 Parenteral Dosage Form Segment by Type
1.2.1 Global Parenteral Dosage Form Market Value Comparison by Type (2023-2029)
1.2.2 Emulsions for Injection
1.2.3 Powders for Injection
1.2.4 Gels for Injection
1.3 Parenteral Dosage Form Segment by Application
1.3.1 Global Parenteral Dosage Form Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Parenteral Dosage Form Market Size Estimates and Forecasts
1.4.1 Global Parenteral Dosage Form Revenue 2018-2029
1.4.2 Global Parenteral Dosage Form Sales 2018-2029
1.4.3 Global Parenteral Dosage Form Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Parenteral Dosage Form Market Competition by Manufacturers
2.1 Global Parenteral Dosage Form Sales Market Share by Manufacturers (2018-2023)
2.2 Global Parenteral Dosage Form Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Parenteral Dosage Form Average Price by Manufacturers (2018-2023)
2.4 Global Parenteral Dosage Form Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Parenteral Dosage Form, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Parenteral Dosage Form, Product Type & Application
2.7 Parenteral Dosage Form Market Competitive Situation and Trends
2.7.1 Parenteral Dosage Form Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Parenteral Dosage Form Players Market Share by Revenue
2.7.3 Global Parenteral Dosage Form Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Parenteral Dosage Form Retrospective Market Scenario by Region
3.1 Global Parenteral Dosage Form Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Parenteral Dosage Form Global Parenteral Dosage Form Sales by Region: 2018-2029
3.2.1 Global Parenteral Dosage Form Sales by Region: 2018-2023
3.2.2 Global Parenteral Dosage Form Sales by Region: 2024-2029
3.3 Global Parenteral Dosage Form Global Parenteral Dosage Form Revenue by Region: 2018-2029
3.3.1 Global Parenteral Dosage Form Revenue by Region: 2018-2023
3.3.2 Global Parenteral Dosage Form Revenue by Region: 2024-2029
3.4 North America Parenteral Dosage Form Market Facts & Figures by Country
3.4.1 North America Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Parenteral Dosage Form Sales by Country (2018-2029)
3.4.3 North America Parenteral Dosage Form Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Parenteral Dosage Form Market Facts & Figures by Country
3.5.1 Europe Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Parenteral Dosage Form Sales by Country (2018-2029)
3.5.3 Europe Parenteral Dosage Form Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Parenteral Dosage Form Market Facts & Figures by Country
3.6.1 Asia Pacific Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Parenteral Dosage Form Sales by Country (2018-2029)
3.6.3 Asia Pacific Parenteral Dosage Form Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Parenteral Dosage Form Market Facts & Figures by Country
3.7.1 Latin America Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Parenteral Dosage Form Sales by Country (2018-2029)
3.7.3 Latin America Parenteral Dosage Form Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Parenteral Dosage Form Market Facts & Figures by Country
3.8.1 Middle East and Africa Parenteral Dosage Form Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Parenteral Dosage Form Sales by Country (2018-2029)
3.8.3 Middle East and Africa Parenteral Dosage Form Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Parenteral Dosage Form Sales by Type (2018-2029)
4.1.1 Global Parenteral Dosage Form Sales by Type (2018-2023)
4.1.2 Global Parenteral Dosage Form Sales by Type (2024-2029)
4.1.3 Global Parenteral Dosage Form Sales Market Share by Type (2018-2029)
4.2 Global Parenteral Dosage Form Revenue by Type (2018-2029)
4.2.1 Global Parenteral Dosage Form Revenue by Type (2018-2023)
4.2.2 Global Parenteral Dosage Form Revenue by Type (2024-2029)
4.2.3 Global Parenteral Dosage Form Revenue Market Share by Type (2018-2029)
4.3 Global Parenteral Dosage Form Price by Type (2018-2029)
5 Segment by Application
5.1 Global Parenteral Dosage Form Sales by Application (2018-2029)
5.1.1 Global Parenteral Dosage Form Sales by Application (2018-2023)
5.1.2 Global Parenteral Dosage Form Sales by Application (2024-2029)
5.1.3 Global Parenteral Dosage Form Sales Market Share by Application (2018-2029)
5.2 Global Parenteral Dosage Form Revenue by Application (2018-2029)
5.2.1 Global Parenteral Dosage Form Revenue by Application (2018-2023)
5.2.2 Global Parenteral Dosage Form Revenue by Application (2024-2029)
5.2.3 Global Parenteral Dosage Form Revenue Market Share by Application (2018-2029)
5.3 Global Parenteral Dosage Form Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Ashland
6.1.1 Ashland Corporation Information
6.1.2 Ashland Description and Business Overview
6.1.3 Ashland Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Ashland Parenteral Dosage Form Product Portfolio
6.1.5 Ashland Recent Developments/Updates
6.2 Tepnel Pharma Services
6.2.1 Tepnel Pharma Services Corporation Information
6.2.2 Tepnel Pharma Services Description and Business Overview
6.2.3 Tepnel Pharma Services Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Tepnel Pharma Services Parenteral Dosage Form Product Portfolio
6.2.5 Tepnel Pharma Services Recent Developments/Updates
6.3 Ascendia Pharmaceuticals
6.3.1 Ascendia Pharmaceuticals Corporation Information
6.3.2 Ascendia Pharmaceuticals Description and Business Overview
6.3.3 Ascendia Pharmaceuticals Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Ascendia Pharmaceuticals Parenteral Dosage Form Product Portfolio
6.3.5 Ascendia Pharmaceuticals Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Thermo Fisher Scientific Parenteral Dosage Form Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 ProJect Pharmaceutics
6.5.1 ProJect Pharmaceutics Corporation Information
6.5.2 ProJect Pharmaceutics Description and Business Overview
6.5.3 ProJect Pharmaceutics Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.5.4 ProJect Pharmaceutics Parenteral Dosage Form Product Portfolio
6.5.5 ProJect Pharmaceutics Recent Developments/Updates
6.6 Lonza
6.6.1 Lonza Corporation Information
6.6.2 Lonza Description and Business Overview
6.6.3 Lonza Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Lonza Parenteral Dosage Form Product Portfolio
6.6.5 Lonza Recent Developments/Updates
6.7 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences Parenteral Dosage Form Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BOC Sciences Parenteral Dosage Form Product Portfolio
6.7.5 BOC Sciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Parenteral Dosage Form Industry Chain Analysis
7.2 Parenteral Dosage Form Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Parenteral Dosage Form Production Mode & Process
7.4 Parenteral Dosage Form Sales and Marketing
7.4.1 Parenteral Dosage Form Sales Channels
7.4.2 Parenteral Dosage Form Distributors
7.5 Parenteral Dosage Form Customers
8 Parenteral Dosage Form Market Dynamics
8.1 Parenteral Dosage Form Industry Trends
8.2 Parenteral Dosage Form Market Drivers
8.3 Parenteral Dosage Form Market Challenges
8.4 Parenteral Dosage Form Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’